Open Trial Obesity CHANGE Program ASD

• ClinicalTrials.gov Identifier: NCT03047018
• Recruitment Status: Completed
• First Posted: February 8, 2017
• Last Update Posted: December 4, 2020
• Sponsor: Emory University
• Information provided by (Responsible Party): William Sharp, PhD, Emory University

Study Description

Brief Summary:

The purpose of this study is to determine if a program can help children with autism who are overweight. Specifically, this study will look to see if changes in a child's eating habits and exercise can help with weight loss. Investigators also want to see how parents feel about the program and if they will complete the entire program.

Twenty children with autism spectrum disorder (ASD) who are also overweight will participate in this study at the Marcus Autism Center. All children who enroll will receive the The Changing Health in Autism through Nutrition, Getting fit and Expanding variety (CHANGE) program. This involves 16 sessions over six months. After the six months, participants will come back every month for three months for a follow up visit. Therefore the study will last a total of nine months.

Condition or disease	Intervention/treatment	Phase
Autism Spectrum Disorder; Obesity	Behavioral: The Changing Health in Autism through Nutrition, Getting fit and Expanding variety (CHANGE) Program	Not Applicable

Detailed Description:

The purpose of this study is to determine if a program can help children with autism who are overweight. Specifically, this study will look to see if changes in a child's eating habits and exercise can help with weight loss. Investigators also want to see how parents feel about the program and if they will complete the entire program.

This is a 24-week, open trial pilot of 20 children (ages 5 to 12 years old) with ASD and obesity. Subjects will be enrolled in the CHANGE program, a six-month long intervention consisting of 16 sessions. The first 10 sessions occur weekly while the remaining 6 sessions occur bi-weekly. Sessions last about 1 hour each. After 24 weeks, subjects will be asked to return for follow up assessments at 1, 2 and 3 months later.

The primary aims of this project are to 1) determine the feasibility of the intervention, 2) examine preliminary efficacy, and 3) obtain feedback from parents to improve the effectiveness of the intervention and fit for families.

Study Design

• Study Type: Interventional (Clinical Trial)
• Actual Enrollment: 35 participants
• Allocation: N/A
• Intervention Model: Single Group Assignment
• Masking: None (Open Label)
• Primary Purpose: Treatment
• Official Title: Open Trial Investigation of the CHANGE (Changing Health in Autism Through Nutrition, Getting Fit and Expanding Variety) Obesity Program
• Actual Study Start Date: October 6, 2017
• Actual Primary Completion Date: March 20, 2020
• Actual Study Completion Date: March 20, 2020

Arms and Interventions

Arm

Intervention/treatment

Experimental: CHANGE Program; Participants with ASD will complete the The Changing Health in Autism through Nutrition, Getting fit and Expanding variety (CHANGE) program.

Behavioral: The Changing Health in Autism through Nutrition, Getting fit and Expanding variety (CHANGE) Program; The CHANGE program is a a six-month long intervention consisting of 16 sessions. The first 10 sessions occur weekly while the remaining 6 sessions occur bi-weekly. Sessions last about 1 hour each. Nutrition intervention focuses on decreasing excess calories from liquids and solids and creating a balanced meal plan. Physical activity intervention uses fading strategies to increase participation in exercise. Behavior strategies promote success with meeting goals. Problem-solving techniques address challenges to adherence with implementing the program in the home setting. The standardized protocols include educational handouts, clinic-based activities and assessment procedures, and caregiver-directed homework and data collection.

Outcome Measures

Primary Outcome Measures :

1. Willingness to Participate [ Time Frame: Baseline through Week 36 Follow Up ]
   Willingness to participate is measured as <30% refusal of study participation from eligible participants. Willingness to participate will be used to measure overall study feasibility.
2. Attendance Rate [ Time Frame: Baseline through Week 36 Follow Up ]
   The number of participants who attend all study visits. The attendance rate will be used to measure overall study feasibility. A successful attendance rate will be measured as >70% attendance.
3. Percent Homework Adherence [ Time Frame: Baseline through Week 36 Follow Up ]
   The percentage of participants who complete all homework assignments. Percent homework adherence will be used to measure overall study feasibility. A successful adherence percentage will be measured as >70%.
4. Percent Demonstration of Skills [ Time Frame: Baseline through Week 36 Follow Up ]
   The percentage of participants who demonstrate skills learned through the CHANGE program. Percent demonstration of skills will be used to measure overall study feasibility. A successful percentage will be measured as >80%.
5. Attrition Rate [ Time Frame: Baseline through Week 36 Follow Up ]
   The number of participants who do not complete all study visits. The attrition rate will be used to measure study feasibility. An acceptable attrition rate will be considered <15%.
6. Percent Satisfaction [ Time Frame: Baseline through Week 36 Follow Up ]
   The percentage of participants who report being satisfied with the intervention. Percent satisfaction will be used to measure overall study feasibility. A successful percentage will be measured as >90%.
7. Therapist Fidelity to the Treatment Manual [ Time Frame: Baseline through Week 36 Follow Up ]
   The percentage of therapists who adhere to the treatment manual. Therapist fidelity will be used to measure overall study feasibility. A successful percentage rate is >80%.

Secondary Outcome Measures :

1. Difference in Body Mass Index (BMI) Percentile [ Time Frame: Baseline through Week 36 Follow Up ]
   The body mass index is a value derived from the mass and height of an individual. The BMI is defined as the body mass divided by the square of the body height.
2. Change in Food Preference Inventory (FPI) Score [ Time Frame: Baseline through Week 36 Follow Up ]
   The FPI is a 154-item, parent-reported measure of food selectivity. This measure provides important information about which foods the child eats across food groups. A food selectivity score is calculated by dividing the number of foods rated "never" by the total number of foods listed.
3. Change in physical activity [ Time Frame: Baseline through Week 36 Follow Up ]
   Physical activity will be measured by parent report and average number of steps by Fitbit data.
4. Change in Parenting Stress Index- Short Form (PSI-SF) Score [ Time Frame: Baseline through Week 36 Follow Up ]
   The PSI-SF is a 36-item survey commonly used measure parental stress. A higher score indicates more parental stress.

Eligibility Criteria

• Ages Eligible for Study: 5 Years to 12 Years (Child)
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Criteria

Inclusion Criteria:

• Diagnosed with ASD using DSM-5 criteria, and clinically significant SCQ score.
• Children with mild to moderate food selectivity, as reflected by a) a diet involving at least 6 food items, b) accepting at least one fruit or vegetable as measured by the Food Preference Inventory (FPI), and c) engaging in low mealtime behavior problems on Brief Autism Mealtime Behavior Inventory (BAMBI) Food Refusal subscale
• Child with a clinic-confirmed body mass index (BMI) percentile in the obese range (i.e., > 95th percentile)
• Parent (primary caregiver) who agrees to participate and attend treatment sessions
• Participating parent able to speak, understand, read, and write in English (assessments, curriculum materials and instructions are in English)

Exclusion Criteria:

• Children with severe feeding problems (e.g., < 5 preferred foods as measured by the FPI) or complex medical issues (e.g., gastrostomy-tube or formula dependent) who require a different treatment approach
• Children on medication associated with weight gain in ASD (e.g., risperidone) that has not yet stabilized (stability criteria defined as 6 months or longer i.e. child has been on medication for less than 6 months).
• Children with serious behavioral problems (i.e., aggression, tantrums, self-injury) or another psychiatric condition that requires a different treatment approach.
• Children with unstable medical conditions or those with a known associated with weight problems will not be included in this study.

Contacts and Locations

Locations

United States, Georgia

Emory University

Atlanta, Georgia, United States, 30308

Sponsors and Collaborators

Emory University

Investigators

• Principal Investigator: William Sharp, PhD; Emory University

More Information

• Responsible Party: William Sharp, PhD, Associate Professor, Emory University
• ClinicalTrials.gov Identifier: NCT03047018
• Other Study ID Numbers: IRB00090911
• First Posted: February 8, 2017
• Last Update Posted: December 4, 2020
• Last Verified: December 2020

Individual Participant Data (IPD) Sharing Statement:

• Plan to Share IPD: No

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No

Keywords provided by William Sharp, PhD, Emory University:

Nutrition

Additional relevant MeSH terms:

Obesity; Autism Spectrum Disorder; Overnutrition; Nutrition Disorders; Overweight; Body Weight; Child Development Disorders, Pervasive; Neurodevelopmental Disorders; Mental Disorders